Congress Asset Management Co. Has $160.57 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Congress Asset Management Co. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 307,630 shares of the medical equipment provider’s stock after buying an additional 364 shares during the period. Intuitive Surgical accounts for approximately 1.1% of Congress Asset Management Co.’s investment portfolio, making the stock its 14th largest holding. Congress Asset Management Co. owned approximately 0.09% of Intuitive Surgical worth $160,571,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. increased its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the 3rd quarter worth $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ISRG shares. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Piper Sandler restated an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Finally, Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $595.55 on Friday. The stock’s 50-day moving average is $559.48 and its 200-day moving average is $519.06. The firm has a market cap of $212.12 billion, a price-to-earnings ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.